It is critical for organizations to have a firm understanding of the CMS 2026 Final Rule to bolster reimbursement, plan service lines and ensure continued access to CCTA, FFR-CT and AI-enabled plaque analysis. 

Can you guess the (lightly disputed) champion of healthcare AI suppliers? Here’s a hint. This company caters to physicians and just this week reached a valuation of $12B. 

The solution combines 11 newly cleared indications and three previously cleared indications into a single workflow.

Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.

Researchers with UT Southwestern Medical Center recently surveyed over 900 women about how they view the technology's deployment in screening. 

The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.

2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. 

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.